| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.093 | 0.1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |